Truncus arteriosus is a rare but serious condition characterized by abnormal development of the main arteries of the heart, resulting in a common truncal origin of the pulmonary artery and aorta. It is a heart defect that is usually seen in newborns and can lead to severe circulatory problems as well as a lack of oxygen in the blood. Normally, the left and right pulmonary arteries separate from the aorta and lead to the lungs, but in the presence of truncus arteriosus, they do not have a separate development. This defect can result in serious complications and high mortality, making early diagnosis and treatment critical.
History of the disease and interesting historical facts
The first descriptions of the arterial trunk can be found in medical works of the 19th century, but it was only at the beginning of the 20th century that it was established that this condition is congenital. In the 1940s, the first surgical operations were performed on patients with this diagnosis, which significantly improved the prognosis for such newborns. Interestingly, the arterial trunk was long considered a rare disease and was practically not subject to study, but with the development of cardiology and the invention of modern diagnostic methods such as echocardiography, large studies began to appear confirming the frequency of this defect.
Epidemiology
According to epidemiological studies, the prevalence of arterial trunk is from 0.2 to 0.3% of the total number of types of all heart defects. The frequency of its occurrence varies, but it is known that this condition can be observed in both boys and girls, although it predominates in boys. According to one of the large decodings, arterial trunk makes up approximately 1-2% of all cases of congenital heart defects, which makes it one of the less common, but serious diseases in cardiology.
Genetic predisposition to this disease
Research shows that truncus arteriosus may have a genetic predisposition. In particular, mutations have been found in genes responsible for the development of the cardiovascular system, such as NOTCH1, TGFBR1, and others. These mutations can lead to a disruption in the process of vascular formation, which ultimately causes truncus arteriosus. In addition, a family history of heart defects can also increase the risk of developing this disease in newborns.
Risk factors for the development of this disease
Risk factors for truncus arteriosus include both genetic and exogenous factors. The list of physical factors includes:
- Mother's age is over 35 years
- Presence of viral or bacterial infections during pregnancy
- Maternal metabolic diseases such as diabetes
Chemical risk factors include:
- Alcohol and drug use during pregnancy
- Exposure to toxins and chemicals
It is also important to consider that certain conditions, such as Down syndrome and other chromosomal abnormalities, may increase the likelihood of this defect.
Diagnosis of this disease
Diagnosis of truncus arteriosus begins with a clinical evaluation, in which the physician may suspect the presence of a defect based on the external examination and anamnesis. The main symptoms of the disease may include:
- Cyanosis
- Increased heart rate
- Difficulty breathing
Laboratory tests play a supporting role, but can help in assessing the health of the newborn. Radiological examinations, primarily echocardiography, are the main diagnostic method. It allows visualization of the anatomy of the heart and blood vessels, as well as assessment of blood flow. For a more detailed assessment, cardiac MRI or CT can be used. It is important to conduct a differential diagnosis with other heart defects, such as transposition of the great vessels or triple junction.
Treatment
Treatment of truncus arteriosus requires a multidisciplinary approach. In the initial stages, the focus is on supporting vital functions and stabilizing the patient's condition. General treatment includes drug therapy to manage hemodynamic parameters.
Pharmacological treatment may include:
- Diuretics to reduce swelling
- Cardiac pacemakers if needed
Surgical treatment involves correcting the anatomy. The operation is most often performed in the first days or weeks of life, depending on the child's condition. Other treatments may include interventional cardiology, such as balloon angloplasty or stenting.
List of medications used to treat this disease
Medications used for truncus arteriosus include:
- Furosemide (Lasix) - to control swelling;
- Digoxin - to improve cardiac function;
- ACE inhibitors - to reduce the load on the heart;
- Peripheral vasodilators - to improve blood flow.
Disease monitoring
Monitoring of the arterial trunk includes regular examinations using echocardiography and clinical assessment of the patient's condition. Control stages are carried out depending on the severity of the defect and the success of surgical intervention. The prognosis for newborns with arterial trunk after surgical treatment is positive, but complications may occur and require further monitoring.
Age-related features of the disease
Truncus arteriosus is usually detected early, but its manifestations may vary depending on age. Newborns often have more pronounced symptoms, while older children may develop complications or manifestations of the disease related to inadequately corrected anatomy.
Questions and Answers
- What is truncus arteriosus? Truncus arteriosus is a congenital heart defect in which the lung and aorta share a common trunk.
- What are the causes of truncus arteriosus? The causes can be varied and include genetic predispositions, exogenous factors during pregnancy and hereditary syndromes.
- How is this disease diagnosed? Diagnosis includes clinical examinations, echocardiography, and other imaging tests to evaluate the heart and blood vessels.
- What treatment is indicated for truncus arteriosus? Treatment includes drug therapy to stabilize the condition and surgical correction to normalize the anatomy of the heart.
- What is the prognosis for patients with truncus arteriosus? The prognosis after surgery can be good, but requires long-term monitoring.
